Exencial Wealth Advisors, LLC Clearside Biomedical, Inc. Transaction History

Exencial Wealth Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$1.35 - $2.88 $18,986 - $40,504	-14,064 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$2.72 - $5.72 $38,254 - $80,446	14,064 New	14,064 $39,000
Q3 2021 Nov 04, 2021	SELL	$4.83 - $7.2 $67,929 - $101,260	-14,064 Closed	0 $0
Q1 2021 May 06, 2021	BUY	$2.24 - $4.25 $31,503 - $59,772	14,064 New	14,064 $35,000

12.1M

54.7K

50.7K

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $68M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Exencial Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Exencial Wealth Advisors, LLC with notifications on news.